Skip to search boxSkip to navigationSkip to main content

Synthesis and in vitro biological evaluation of new pyrimidines as glucagon-like peptide-1 receptor agonists

  • Shaikha S. AlNeyadi
    ,
  • Abdu Adem(corresponding author)
    ,
  • Naheed Amer
    ,
  • Alaa A. Salem
    ,
  • Ibrahim M. Abdou
*Corresponding author for this work
  • United Arab Emirates University
Research Output:
Contribution to journal
Article
Research
Peer-review

Abstract

The therapeutic success of peptide glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of type 2 diabetes mellitus has inspired discovery efforts aimed at developing orally available small-molecule GLP-1 receptor agonists. In this study, two series of new pyrimidine derivatives were designed and synthesized using an efficient route, and were evaluated in terms of GLP-1 receptor agonist activity. In the first series, novel pyrimidines substituted at positions 2 and 4 with groups varying in size and electronic properties were synthesized in a good yield (78–90%). In the second series, the designed pyrimidine templates included both urea and Schiff base linkers, and these compounds were successfully produced with yields of 77–84%. In vitro experiments with cultured cells showed that compounds 3a and 10a (10−15–10−9 M) significantly increased insulin secretion compared to that of the control cells in both the absence and presence of 2.8 mM glucose; compound 8b only demonstrated significance in the absence of glucose. These findings represent a valuable starting point for the design and discovery of small-molecule GLP-1 receptor agonists that can be administered orally.

Research Output Information

Output type

Research Output:
Contribution to journal
Article
Research
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 5071-5075 (5 pages)

Journal (Volume, Issue Number)

Bioorganic and Medicinal Chemistry Letters (Volume 27, Issue 22)

Publication milestones

  • Published - 15/11/2017

Publication status

Published - 15/11/2017

ISSN

0960-894X

Publication IDs

  • Scopus: 85030569246
  • PubMed: 28988756

Publication metrics

Metrics

SciVal
FWCI
0.21
Scopus
citations

PlumX, opens in new tab

Captures
16
Citation count
3

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well